Literature DB >> 18560791

Limitations of the Mini-Mental State Examination for screening dementia in a community with low socioeconomic status: results from the Sao Paulo Ageing & Health Study.

Marcia Scazufca1, Osvaldo P Almeida, Homero P Vallada, Wernestty A Tasse, Paulo R Menezes.   

Abstract

BACKGROUND: The Mini-Mental State Examination (MMSE) is the most widely used instrument for the screening of cognitive impairment worldwide, but its ability to produce valid estimates of dementia in populations of low socioeconomic status and minimal literacy skills has not been adequately established. The authors investigated the psychometric properties of the MMSE in a community-based sample of older Brazilians.
METHOD: Cross-sectional one-phase population-based study of all residents of pre-defined areas of the city of Sao Paulo, aged 65 years or over. The Brazilian version of the MMSE was compared with DSM-IV diagnosis of dementia assessed with a harmonized one-phase procedure developed by the 10/66 Dementia Research Group.
RESULTS: Analyses were performed with 1,933 participants of the SPAH study. Receiver operating characteristic analysis showed that the MMSE cut-point of 14/15 was associated with 78.7% sensitivity and 77.8% specificity for the diagnosis of dementia amongst participants with no formal education, and the cut-point 17/18 with 91.9% sensitivity and 89.5% specificity for those with at least 1 year of formal education (areas under the curves 0.87 and 0.94, respectively; P = 0.03). Even with these best fitting cut-points, the MMSE estimate of the prevalence of dementia was four times higher than determined by the DSM-IV criteria. Education, age, sex and income influenced MMSE scores, independently of dementia caseness.
CONCLUSION: The MMSE is an adequate tool for screening dementia in older adults with minimum literacy skills, but misclassification is unacceptably high for older adults who are illiterate, which has serious consequences for research and clinical practice in low and middle income countries, where the proportion of illiteracy among older adults is high.

Entities:  

Mesh:

Year:  2008        PMID: 18560791     DOI: 10.1007/s00406-008-0827-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  30 in total

1.  Methodological issues for population-based research into dementia in developing countries. A position paper from the 10/66 Dementia Research Group.

Authors:  M Prince
Journal:  Int J Geriatr Psychiatry       Date:  2000-01       Impact factor: 3.485

2.  [Mini-Mental State Examination: psychometric characteristics in elderly outpatients].

Authors:  Roberto A Lourenço; Renato P Veras
Journal:  Rev Saude Publica       Date:  2006-08-08       Impact factor: 2.106

3.  Mini-Mental State Examination norms in a community-dwelling sample of elderly with low schooling in Brazil.

Authors:  Jerson Laks; Elienai Maria Rubim Baptista; Ana Lúcia Barros Contino; Estevão Oliveira de Paula; Eliasz Engelhardt
Journal:  Cad Saude Publica       Date:  2007-02       Impact factor: 1.632

4.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

5.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT.

Authors:  J R Copeland; M E Dewey; H M Griffiths-Jones
Journal:  Psychol Med       Date:  1986-02       Impact factor: 7.723

6.  Mini-Mental State Examination. Norms, normals, and numbers.

Authors:  J L Cummings
Journal:  JAMA       Date:  1993-05-12       Impact factor: 56.272

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

8.  Norms for the Mini-Mental State Examination in a healthy population.

Authors:  F Grigoletto; G Zappalà; D W Anderson; B D Lebowitz
Journal:  Neurology       Date:  1999-07-22       Impact factor: 9.910

9.  [Mini mental state examination and the diagnosis of dementia in Brazil].

Authors:  O P Almeida
Journal:  Arq Neuropsiquiatr       Date:  1998-09       Impact factor: 1.420

10.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

View more
  41 in total

1.  The relationship between education level and mini-mental state examination domains among older Mexican Americans.

Authors:  Diana Matallana; Cecilia de Santacruz; Carlos Cano; Pablo Reyes; Rafael Samper-Ternent; Kyriakos S Markides; Kenneth J Ottenbacher; Carlos A Reyes-Ortiz
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-06-10       Impact factor: 2.680

2.  Impact of sociodemographic and health variables on mini-mental state examination in a community-based sample of older people.

Authors:  Camila Moraes; Jony Arrais Pinto; Marcos Antônio Lopes; Julio Litvoc; Cassio M C Bottino
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-19       Impact factor: 5.270

3.  Cognitive function and oral health-related quality of life in older adults.

Authors:  Kyung Hee Lee; Bei Wu; Brenda L Plassman
Journal:  J Am Geriatr Soc       Date:  2013-08-26       Impact factor: 5.562

4.  Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8.

Authors:  Christopher R Carpenter; Elizabeth R Bassett; Grant M Fischer; Jonathan Shirshekan; James E Galvin; John C Morris
Journal:  Acad Emerg Med       Date:  2011-04       Impact factor: 3.451

5.  A quick test of cognitive speed (AQT): usefulness in dementia evaluations in primary care.

Authors:  Anna S Kvitting; Anders Wimo; Maria M Johansson; Jan Marcusson
Journal:  Scand J Prim Health Care       Date:  2013-01-07       Impact factor: 2.581

6.  The Six-Item Screener and AD8 for the detection of cognitive impairment in geriatric emergency department patients.

Authors:  Christopher R Carpenter; Bobby DesPain; Travis N Keeling; Mansi Shah; Morgan Rothenberger
Journal:  Ann Emerg Med       Date:  2010-09-19       Impact factor: 5.721

7.  Validation of the 10/66 Dementia Research Group diagnostic assessment for dementia in Arabic: a study in Lebanon.

Authors:  Kieu T T Phung; Monique Chaaya; Gunhild Waldemar; Samir Atweh; Khalil Asmar; Husam Ghusn; Georges Karam; Raja Sawaya; Rose Mary Khoury; Ibrahim Zeinaty; Sandrine Salman; Salem Hammoud; Wael Radwan; Nazem Bassil; Martin Prince
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-04-25       Impact factor: 2.680

8.  A Population-Based Study of Intracerebral Hemorrhage Survivors' Outcomes.

Authors:  Julius Griauzde; Lynda D Lisabeth; Chengwei Li; Brisa N Sanchez; Erin Case; Nelda M Garcia; Lewis B Morgenstern; Darin B Zahuranec
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-09-28       Impact factor: 2.136

9.  Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly.

Authors:  Rodolfo B Ladeira; Breno S Diniz; Paula V Nunes; Orestes V Forlenza
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer.

Authors:  Reena V Jayani; Allison M Magnuson; Can-Lan Sun; Huiyan Ma; William P Tew; Supriya G Mohile; Ajeet Gajra; Heidi D Klepin; Cary P Gross; Hyman B Muss; Andrew E Chapman; Vani Katheria; Arti Hurria; William Dale
Journal:  J Geriatr Oncol       Date:  2019-12-06       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.